Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Eli Lilly & Co. (LLY) Plans Expansion of San Diego-Located Biotechnology Center
July 23, 2015 6:33 AM EDTEli Lilly & Co. (NYSE: LLY) revealed plans to expand the Lilly Biotechnology Center located in San Diego, Calif. The expansion will effectively double Lilly's research presence in San Diego as the company seeks to develop new collaborations in one of the world's leading regions for drug research and development.
Set to be completed in 2016, the expansion will feature an additional 175,000 square feet of working space and is expected to generate up to 130 potential new job openings, yielding a... More
Eli Lilly & Co. (LLY) Tops Q2 EPS by 16c; Updates FY15 Outlook
July 23, 2015 6:26 AM EDTEli Lilly & Co. (NYSE: LLY) reported Q2 EPS of $0.90, $0.16 better than the analyst estimate of $0.74. Revenue for the quarter came in at $4.98 billion versus the consensus estimate of $4.89 billion.
The following table summarizes the company's 2015 financial guidance:
... More
